Verici Dx (VRCI) Competitors

Verici Dx (LON:VRCI) and GENinCode (LON:GENI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.

Do analysts recommend VRCI or GENI?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verici Dx	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
GENinCode	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community favor VRCI or GENI?

Verici Dx and GENinCode both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
Verici Dx	N/A	N/A
GENinCode	N/A	N/A

Is VRCI or GENI more profitable?

GENinCode's return on equity of -84.23% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	N/A	-92.28%	-47.86%
GENinCode	N/A	-84.23%	-43.64%

Do institutionals & insiders have more ownership in VRCI or GENI?

47.3% of Verici Dx shares are owned by institutional investors. Comparatively, 45.2% of GENinCode shares are owned by institutional investors. 17.0% of Verici Dx shares are owned by company insiders. Comparatively, 31.4% of GENinCode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media prefer VRCI or GENI?

In the previous week, Verici Dx had 1 more articles in the media than GENinCode. MarketBeat recorded 1 mentions for Verici Dx and 0 mentions for GENinCode. GENinCode's average media sentiment score of 0.00 beat Verici Dx's score of -1.27 indicating that GENinCode is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Negative
GENinCode	Neutral

Which has more volatility & risk, VRCI or GENI?

Verici Dx has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, GENinCode has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500.

Which has better valuation & earnings, VRCI or GENI?

GENinCode has higher revenue and earnings than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	N/A	N/A	-£11.21M	-£0.05	-155.00
GENinCode	£1.72M	8.11	-£6.73M	-£0.06	-131.33

Summary

GENinCode beats Verici Dx on 7 of the 11 factors compared between the two stocks.